SUMMARY We have investigated the possibility that the abnormally decreased gall bladder contraction after meals in patients with coeliac disease might result in part from an abnormality in the gall bladder response to endogenous cholecystokinetic hormones -for example, cholecystokinin and motilin -rather than solely from decreased secretion of such hormones. Eight patients with untreated coeliac disease and nine controls received intravenous infusions of the pure synthetic cholecystokinin analogue caerulein, 2-16 ng/kg/hour. Gall bladder emptying was measured on a minute-by-minute basis using ssniTc-HIDA scans. In the patients with coeliac disease, gall bladder emptying was greatly decreased (34.6±9.9 v 615+7±5% at 60 minutes, p<O.02), and a much greater dose of caerulein was needed to initiate gall bladder contraction (3.80±1.08 v 1-49±0 56 ng/kg, p<002). These results suggest that the abnormal gall bladder contraction in coeliac disease is not simply because of impaired release of cholecystokinin. Although mechanical factors secondary to the increased gall bladder size in patients with coeliac disease might to some extent account for the findings, the alternative explanation is that the gall bladder muscle is for some reason resistant to the action of cholecystokinetic agents. A similar phenomenon affecting the pancreas might contribute to the abnormally decreased pancreatic secretion found in coeliac disease.
The peptide hormone cholecystokinin is released from the mucosa of the upper small intestine after meals, and is believed to constitute the major stimulus to postprandial gall bladder emptying, although other peptide hormones, such as motilin, may also play a part.' In patients with coeliac disease there is decreased gall bladder contraction after meals,' and pancreatic enzyme secretion is similarly decreased.6 These factors could conceivably contribute to the malabsorption which is a prominent feature of the condition. Because for a variety of reasons radioimmunoassay and other assay methods for cholecystokinin are unusually difficult,78 the exact pathogenesis of the impaired gall bladder emptying after meals in patients with coeliac disease is still uncertain. The most obvious explanation is that there may be insufficient release of cholecystokinin (and perhaps also other cholecystokinetic agents, such as motilin) from the abnormal small intestinal mucosa.9 "'There certainly appears to be an impaired release of cholecystokinin after meals,"4' yet two observations suggest this is not the only abnormality. Braganza and Howat and later Delamarre et al both reported an impaired response to injections of cholecystokinin, indicating an abnormality at gall bladder level." In this study, we used a cholescintigraphic method to see whether an impaired responsiveness of the gall bladder to cholecystokinetic agents could be shown in patients with untreated coeliac disease. anaemia or both. Coeliac disease was diagnosed by the finding of subtotal villous atrophy on jejunal biopsy, with a satisfactory response to a gluten free diet. In the control volunteers there were no symptoms of gastrointestinal tract disease, and no abnormalities of blood count, erythrocyte morphology, plasma proteins, urea or electrolytes. Occult gall stones were excluded in both groups by using grey scale ultrasonography. Gall bladder emptying was studied using a very precise isotope technique, in which the radioactive compound`mTc Hydroxyimino diacetic acid (HIDA) is injected intravenously, and accumulates in the gall bladder after being excreted in the bile.'3 14 Because commercially available preparations of cholecystokinin are either impure or very expensive, we used the pure, synthetic and stable cholecystokinin analogue caerulein as the stimulus to gall bladder emptying.5 16 Studies were carried out after an overnight fast, using a gamma camera (IGE 400T Maxicamera) fitted with a high resolution collimator interfaced to a microcomputer system. With the subject in the supine position, 185-370 Bq/kg body weight (=5-10 ,uCi/kg) of the imino diacetic acid derivative`mTc-HIDA were injected intravenously. Serial scintiscan images of one minute duration, centred over the liver and gall bladder, were obtained for the next 160 minutes.
It was invariably found that over 90% of the isotope had been excreted by the liver and had accumulated in the gall bladder by 75 minutes after the injection. At (Fig. 1) .
The rate of gall bladder emptying was calculated by measuring the rate at which the radioactive`'mTc-HIDA left the gall bladder, using the method of Krishnamurthy et al,'3 with minor modifications to allow for blood and organ background, movements of the subject and isotopic decay. Isotope distribution was recorded by the gamma camera (Figs 2-4) , on a minute-by-minute basis, and stored on computer tape for a later analysis.
The emptying of isotope from the gall bladder was measured continuously (Fig. 1) , and gall bladder response to the infusion of caerulein was assessed by calculating the time at which emptying began (taken as a fall of 10% in gall bladder radioactivity), the dose of caerulein required to initiate emptying, the maxi- mum emptying rate and the time at which this occurred, and the total percentage emptying by the end of the caerulein infusion.
Results
Patients with coeliac disease required a considerably larger dose of caerulein to initiate gall bladder emptying (3-80±1-08 v 1-49±0-56 ng/kg, p<0-02), and there was a correspondingly longer delay from the start of the infusion until emptying began. The speed of gall bladder emptying tended to be slower than normal in patients with coeliac disease, but this was not statistically significant. By the end of the 60 minute infusion of caerulein, gall bladder emptying was less complete in the patients than in the controls (percentage emptying at end of caerulein infusion 34-6±9*9 v 61*5±7-5, p<0-02). A summary of the results is given in the table (Table) and illustrated in Figure 5 .
The statistical significance of differences in the various measurements listed in the Table between control subjects and patients with coeliac disease was assessed using Student's t test. All statistically significant differences were checked with the Wilcoxon's signed-rank test, and similar results were obtained. Despite these latter observations, it is still possible that the gall bladder abnormality could simply reflect a mechanical phenomenon resulting from its increased size in coeliac disease. If the gall bladder volume was 3(0 greater in some patients, they might expel a similar total volume of bile to that of normal subjects, yet this would not be reflected in the change of gall bladder radioactivity, which shows emptying as a proportion of original gall bladder volume rather than as an absolute volume change. A similar theory could be used to explain the greater threshold dose of caerulein required to initiate emptying. In order to generate enough intraluminal pressure to empty the gall bladder, the gall bladder muscle must shorten by a certain length. Because the muscle fibres are presumably larger in the dilated gall bladder of coeliac patients, they must shorten more in order to initiate emptying. Hence a larger amount of caerulein (or CCK) might be required. This theory could be tested relatively easily by carrying out similar studies to this one but using volumemeasuring techniques such as ultrasonography to assess gall bladder volume changes directly.
If the abnormality lay at the receptor site level, there are various factors which might influence the responsiveness of the gall bladder CCK receptor to cholecystokinin ( In the study of Low-Beer et al' which used a very sensitive radioimmunassay for cholecystokinin,' fasting concentrations of CCK were found to be abnormally raised in patients with coeliac disease, although the rise in response to a meal was abnormally low. This puzzling finding has not been confirmed by any other study, but this may be because in the only two reports which have been published up to the present time, the sensitivity of the assays used was not sufficient to detect fasting plasma concentrations of CCK in either normal subjects or patients with coeliac disease.4"' Alternatively this may have been an anomalous result of some sort of assay artefact, as no two centres using CCK radioimmunoassay techniques seem able to agree on their methods or results. The number of CCK secreting endocrine cells in the small intestinal mucosa of patients with coeliac disease is abnormally increased.33' Such hyperplasia of CCK cells would be consistent with increased basal secretion of CCK in coeliac disease, similar to the hyperplasia of gastrin secreting cells in the antrum of patients with achlorhydria and hypergastrinaemia. Whether in fact this does occur, and if so, what mechanisms are involved, must await further studies. The possible relevance to the current study is that the effect of constant low level stimulation of the CCK receptor by increased basal CCK concentrations Finally, it is possible that gall bladder contraction in coeliac disease might be inhibited by a nervous mechanism. Reflexes from the upper gastrointestinal tract to the gall bladder have been described,-4 but relatively little is known about them. Contrary to current opinion, however, the action of CCK on the gall bladder is to some extent dependent on nervous influences, as can be shown by the inhibitory effect of atropine on CCK induced gall bladder contraction." If patients with coeliac disease have a circulaiting inhibitor of the effect of CCK, then it might well act on the pancreas as well as the gall bladder, as the intracellular consequences of CCK acting on its receptor are similar in the two organs."-7 A decreased response of the pancreas to intraduodenal amino acids has been reported in coeliac disease, and was originally interpreted as being solely because of impaired CCK release, as injection of large doses of CCK produced normal enzyme secretion in these patients.' Later studies have shown, however, that if smaller doses of CCK are injected, abnormally decreased pancreatic enzyme secretion can be shown in many patients with coeliac disease."' " If this is indeed the case, it makes the 'mechanical' explanation of our findings -that is, that they result simply from increased gall bladder size, rather less likely. It is more probable that whatever is affecting the gall bladder response to CCK is also affecting the response of the pancreas, where presumably a similar list of possible explanations as to the exact mechanism of this finding applies.
Thus 
